Dibaglim PM 2mg/500mg/15mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Dibaglim PM 2mg/500mg/15mg Tablet
Combiflex DM 2mg/500mg/15mg tablets offer triple-action blood sugar management. This combination medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood glucose. Always adhere to your physician's prescribed dosage and regimen for Combiflex DM. Take with food to prevent gastric discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling the dose. Overdosage can cause hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals elevates hypoglycemia risk; consistent blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to minimize potential side effects.
Primary Ingredients of Dibaglim PM 2mg/500mg/15mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Dibaglim PM 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Dibaglim PM 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dibaglim PM 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Dibaglim PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Dibaglim PM 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dibaglim PM 2mg/500mg/15mg Tablet should be administered with a meal.
How Dibaglim PM 2mg/500mg/15mg Tablet works:
Dibaglim PM 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when single or dual drug therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity within the body.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dibaglim PM 2mg/500mg/15mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Dibaglim PM 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Dibaglim PM 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms manifest.
KidneyCAUTION
Patients with kidney impairment should use Dibaglim PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dibaglim PM 2mg/500mg/15mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Dibaglim PM 2mg/500mg/15mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised. The use of Dibaglim PM 2mg/500mg/15mg tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Dibaglim PM 2mg/500mg/15mg Tablet :
Should you forget a dose of Dibaglim PM 2mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dibaglim PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently